Lodelcizumab (Anti-PCSK9)

Lodelcizumab is a human monoclonal antibody targated against proprotein convertase subtilisin/kexin type 9 (PCSK9) with the potential to be used in research on hypercholesterolemia. MW: 145.66 KD.

• Supplier: Selleck Chemicals
• Product #: A2924
• Sku #: A2924-1mg*25